Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1182597

registered interest
date	04/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nappies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of reusable nappies on childhood toilet training.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	25156
answer	answer is ministerial correction date of answer 09/03/2020 answer text <p>No such assessment has been made.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/03/2020 17:59:57 answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1182598

registered interest
date	04/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nappies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of disposable nappies on rates of diagnosis of bladder and bowel issues in children.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	25157
answer	answer is ministerial correction date of answer 09/03/2020 answer text <p>An assessment has not been made of the effect of disposable nappies on incidences of bladder and bowel issues in children.</p><p>Public Health England continues to monitor the issue.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/03/2020 16:37:49 answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1180728

registered interest
date	26/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish guidance for (a) medical professionals and (b) the public on access to medicines at the end of the transition period.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	21282
answer	answer is ministerial correction date of answer 02/03/2020 answer text <p>The United Kingdom has now left the European Union and entered a transition period, which will run until 31 December 2020. EU regulations on medicines, vaccines and medical devices will continue to apply to the UK throughout the transition period, during which we will negotiate a new trade agreement with the EU.</p><p> </p><p>Both the EU and the UK are committed to agreeing a future partnership by the end of 2020 and are working to achieve this. It is in the interests of both the UK and the EU to agree a future partnership that keeps goods flowing, services provided, and business carried out as usual.</p><p> </p><p>The Department, NHS England and NHS Improvement will continue to keep medical professionals and the public updated with relevant communications on medicines as the need arises.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 02/03/2020 15:38:55 answering member 4362 label Biography information for Edward Argar
tabling member	4488 label Biography information for Martyn Day

1180920

registered interest
date	26/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) increase the adequacy of and (b) reduce the waiting time for the appraisal process for blood cancer patients to receive treatment.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	21364
answer	answer is ministerial correction date of answer 06/03/2020 answer text <p>The National Institute for Health and Care Excellence (NICE) is committed to publishing guidance within 90 days of a new cancer drug receiving its licence. If NICE’s draft recommendation, which can be published before a licence is granted, is positive, NHS England will make funding available immediately from when the license becomes effective and before the final guidance is published. The forecasted mean time from a new cancer drug receiving its licence to published final guidance in 2020/21 is now 1.5 months, a reduction of 13.5 months from 2012/13.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 06/03/2020 13:13:09 answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1180925

registered interest
date	26/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure GPs are using the latest NICE cancer symptom guidance on diagnosing blood cancer symptoms.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	21367
answer	answer is ministerial correction date of answer 06/03/2020 answer text <p>Once the National Institute for Health and Care Excellence (NICE) publishes clinical guidance, health professionals and the organisations that employ them are expected to take it into account when deciding what treatments are suitable for each patient.</p><p>NICE updated referral guidelines for suspected cancer published in June 2015 with general practitioners urged to think of cancer sooner and lower the referral threshold for tests.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 06/03/2020 12:44:51 answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1168367

registered interest
date	19/12/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of applying the precautionary principle to the introduction of 5G technology until further evidence of its safety to the public is available.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	169
answer	answer is ministerial correction date of answer 10/01/2020 answer text <p>Public Health England provides advice on protection from exposure to the radio waves from telecommunications systems, including those providing 5G services.</p><p> </p><p>PHE has published information about exposure to the radio waves from mobile phone base stations, including those for 5G networks which are at the following links:</p><p> </p><p><a href="https://www.gov.uk/government/publications/5g-technologies-radio-waves-and-health/5g-technologies-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/5g-technologies-radio-waves-and-health/5g-technologies-radio-waves-and-health</a></p><p> </p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p> </p><p>These resources explain the extensive research that has been performed on exposure to radio waves, the conclusions that have been reached by expert groups which have examined the evidence at national and international levels, as well as the practical measures that are already in place to protect public health.</p><p> </p><p>PHE is committed to monitoring the evidence applicable to 5G and other radio technologies, and to revising its advice, should that be necessary.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 170 question first answered 10/01/2020 14:09:08 answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1168369

registered interest
date	19/12/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	5G: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will apply the precautionary principle to the roll out of 5G in the UK.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	170
answer	answer is ministerial correction date of answer 10/01/2020 answer text <p>Public Health England provides advice on protection from exposure to the radio waves from telecommunications systems, including those providing 5G services.</p><p> </p><p>PHE has published information about exposure to the radio waves from mobile phone base stations, including those for 5G networks which are at the following links:</p><p> </p><p><a href="https://www.gov.uk/government/publications/5g-technologies-radio-waves-and-health/5g-technologies-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/5g-technologies-radio-waves-and-health/5g-technologies-radio-waves-and-health</a></p><p> </p><p><a href="https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health" target="_blank">https://www.gov.uk/government/publications/mobile-phone-base-stations-radio-waves-and-health/mobile-phone-base-stations-radio-waves-and-health</a></p><p> </p><p>These resources explain the extensive research that has been performed on exposure to radio waves, the conclusions that have been reached by expert groups which have examined the evidence at national and international levels, as well as the practical measures that are already in place to protect public health.</p><p> </p><p>PHE is committed to monitoring the evidence applicable to 5G and other radio technologies, and to revising its advice, should that be necessary.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 169 question first answered 10/01/2020 14:09:08 answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1132453

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Arthritis: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to (a) ensure patient safety and (b) support pioneering medical research to tackle (i) rheumatoid arthritis and (ii) other inflammatory conditions in the event that the UK leaves the EU without a deal.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	265579
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The Government remains committed to leaving the European Union with a deal. However, as a responsible Government, we must plan for every eventuality, including no deal.</p><p>We have been working closely with partners across the health and care system and industry to ensure the continued health and safety of patients, including ensuring supplies of medicines and medical products, and securing the future of our EU health and care workforce.</p><p>The Department has published EU Exit operational readiness guidance for the health and care system in England outlining actions that providers and commissioners of health and social care services should take to prepare for, and manage, the risks of a no deal exit scenario.</p><p>We continue to monitor and analyse overall staffing levels across the National Health Service and adult social care, and we are working across Government to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies following the UK’s exit from the EU.</p><p>The UK has an outstanding track record for research into rheumatoid arthritis and other inflammatory conditions. The Government invests over £1 billion in health research through the National Institute for Health Research (NIHR). This provides direct funding for health research and clinical trials and also the skills, facilities and infrastructure to undertake clinical trials in the health and care service funded by public, charity and industry funders.</p><p>In 2017/18, the NIHR provided £11.7 million funding for research on the inflammatory and immune system (this includes rheumatoid arthritis, connective tissue diseases, autoimmune diseases, allergies and normal development and function of the immune system, as per the UK Clinical Research Collaboration Health Research Classification System, of which £1.2 million was for research on rheumatoid arthritis. In addition, the NIHR Clinical Research Network provides the support to deliver research by public, charity and industry funders in the health and care system.</p><p>The UK and the EU have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation, including in pioneering medical research for rheumatoid arthritis and other inflammatory conditions.</p><p>As a responsible Government, we are continuing to prepare for all scenarios. In the event that the UK leaves the EU without a deal at the end of this extension period, the Government has confirmed that the funding commitments made under the guarantee and the extension still stand. Through these commitments, the Government will underwrite funding for all successful competitive eligible UK bids to Horizon 2020 that are submitted before the end of the Programme. This guarantee will apply for the lifetime of projects and will provide funding for UK participation in pioneering Horizon 2020 medical research projects can continue.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/06/2019 15:36:21 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4488 label Biography information for Martyn Day